Literature DB >> 34176285

Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension.

Cyndya A Shibao1, Jose-Alberto Palma2, Jorge E Celedonio1, Jose Martinez2, Horacio Kaufmann2, Italo Biaggioni1.   

Abstract

[Figure: see text].

Entities:  

Keywords:  Parkinson disease; biomarker; hypotension, orthostatic; norepinephrine; pure autonomic failure

Mesh：

Substances：

Year:  2021        PMID： 34176285      PMCID： PMC9192331          DOI： 10.1161/HYPERTENSIONAHA.119.14483

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


  25 in total

1.  Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure.

Authors:  H Kaufmann; K Hague; D Perl
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

2.  Norepinephrine transporter inhibitors and their therapeutic potential.

Authors:  Jia Zhou
Journal:  Drugs Future       Date:  2004-12       Impact factor: 0.148

3.  Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Jose Martinez; Horacio Kaufmann
Journal:  Neurology       Date:  2018-09-19       Impact factor: 9.910

4.  Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.

Authors:  Claudia E Ramirez; Luis E Okamoto; Amy C Arnold; Alfredo Gamboa; André Diedrich; Leena Choi; Satish R Raj; David Robertson; Italo Biaggioni; Cyndya A Shibao
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

5.  Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast.

Authors:  Neil Easton; Fiona Marshall; Kevin Fone; Charles Marsden
Journal:  Neuropharmacology       Date:  2006-11-29       Impact factor: 5.250

6.  The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.

Authors:  Horacio Kaufmann; Richard Malamut; Lucy Norcliffe-Kaufmann; Kathleen Rosa; Roy Freeman
Journal:  Clin Auton Res       Date:  2011-11-02       Impact factor: 4.435

7.  Optimization of high-performance liquid chromatographic assay for catecholamines. Determination of optimal mobile phase composition and elimination of species-dependent differences in extraction recovery of 3,4-dihydroxybenzylamine.

Authors:  H B He; R J Deegan; M Wood; A J Wood
Journal:  J Chromatogr       Date:  1992-02-14

8.  Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.

Authors:  Jun Mitsui; Yuko Saito; Toshimitsu Momose; Jun Shimizu; Noritoshi Arai; Junji Shibahara; Yoshikazu Ugawa; Ichiro Kanazawa; Shoji Tsuji; Shigeo Murayama
Journal:  J Neurol Sci       Date:  2006-01-27       Impact factor: 3.181

9.  Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy.

Authors:  Satoshi Orimo; Toshiro Kanazawa; Ayako Nakamura; Toshiki Uchihara; Fumiaki Mori; Akiyoshi Kakita; Koichi Wakabayashi; Hitoshi Takahashi
Journal:  Acta Neuropathol       Date:  2006-11-07       Impact factor: 17.088

10.  Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach.

Authors:  Andre F Marquand; Owen G O'Daly; Sara De Simoni; David C Alsop; R Paul Maguire; Steven C R Williams; Fernando O Zelaya; Mitul A Mehta
Journal:  Neuroimage       Date:  2012-01-14       Impact factor: 6.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.